Stevens-Johnson syndrome is a rare but severe medical emergency that transforms a reaction to medication or infection into a life-threatening skin condition, requiring immediate hospitalization and intensive care to prevent devastating complications.

Stevens-Johnson syndrome, often abbreviated as SJS, represents one of the most serious skin reactions that can occur in the human body. This condition strikes suddenly and without warning, causing the skin and mucous membranes to react in a way that resembles a severe burn injury. The top layer of skin begins to die and separate from the layers beneath, creating painful blisters that eventually burst and leave raw, exposed areas vulnerable to infection and fluid loss.^[1]

What makes this condition particularly frightening is how quickly it can escalate. Within days, a person who feels slightly unwell can find themselves in a hospital intensive care unit fighting for their life. The condition doesn’t just affect the skin on the outside of the body—it also damages the delicate tissues inside the mouth, throat, eyes, and genital areas, making everyday activities like eating, swallowing, and urinating excruciatingly painful.^[2]

The medical community recognizes Stevens-Johnson syndrome as part of a spectrum of similar conditions. When less than ten percent of the body surface is affected, doctors diagnose it as SJS. When more than thirty percent of the body is involved, it becomes toxic epidermal necrolysis (TEN), which is the most severe form. Cases falling between these percentages are classified as overlap SJS/TEN. Despite these technical distinctions, all forms require emergency treatment because they can all be fatal.^[6]

Epidemiology

Stevens-Johnson syndrome is extremely rare, which offers some comfort to those taking medications that might trigger it. The condition affects approximately one to two people per million each year in Western populations, with toxic epidermal necrolysis being even less common at 0.4 to 1.2 cases per million annually.^[8] In the United States, similar incidence rates have been reported, with studies documenting around 1.9 cases of TEN per million people each year.^[9]

The disease does not discriminate entirely, but certain patterns have emerged from years of medical observation. Women appear to develop Stevens-Johnson syndrome slightly more often than men. The condition can strike at any age, but many cases occur in children and adults younger than thirty years old. However, elderly individuals are also vulnerable, and when they develop the condition, their outcomes tend to be more serious.^[2]

Geographic and ethnic differences also play a role in who develops this condition. Certain genetic markers found more commonly in specific populations increase the risk. For example, people of Asian descent, particularly those of Han Chinese and South Asian Indian heritage, have a higher likelihood of developing SJS when taking certain medications because of a genetic factor called human leukocyte antigen HLA-B*1502.^[9] This genetic connection has become so well established that some countries now require genetic testing before prescribing certain medications to at-risk populations.

People living with HIV face a dramatically elevated risk—they are one hundred times more likely to develop Stevens-Johnson syndrome compared to the general population. This increased susceptibility likely relates to their altered immune function and the medications they must take to manage their condition.^[8]

Causes

The overwhelming majority of Stevens-Johnson syndrome cases—more than eighty percent—result from adverse reactions to medications. The body’s immune system, which normally protects against infections and foreign invaders, mistakenly identifies certain drugs as dangerous threats and launches an aggressive attack that ends up destroying the skin and mucous membranes.^[6]

Several categories of medications have earned reputations as frequent culprits. Antibiotics containing sulfonamides, often called sulfa drugs, rank among the most common triggers. These include medications like sulfamethoxazole, which is commonly combined with trimethoprim to treat urinary tract infections and other bacterial illnesses. Other antibiotics that can trigger SJS include penicillins, cephalosporins, and fluoroquinolones.^[8]

Medications used to control seizures represent another major category of SJS-inducing drugs. Anti-epileptic medications such as phenytoin, carbamazepine, lamotrigine, and phenobarbital have all been implicated in cases of Stevens-Johnson syndrome. People starting these medications need careful monitoring during the first several weeks of treatment, as this is when reactions typically occur.^[2]

Pain medications can also trigger this devastating reaction. While common over-the-counter drugs like acetaminophen (paracetamol) and ibuprofen rarely cause problems, certain prescription non-steroidal anti-inflammatory drugs, particularly those of the oxicam type like piroxicam and meloxicam, carry higher risks. The medication allopurinol, used to treat gout and kidney stones, is another well-known trigger, especially in certain Asian populations.^[3]

In children, infections often cause Stevens-Johnson syndrome more frequently than medications do. Viral infections resembling cold or flu, along with bacterial infections like Mycoplasma pneumoniae (a type of pneumonia), can trigger the condition. Other infectious triggers include herpes viruses, Epstein-Barr virus (which causes glandular fever), and hepatitis A.^[5]

What remains puzzling to doctors is that in about twenty percent of cases, no clear trigger can be identified despite thorough investigation. The condition appears spontaneously, leaving patients and their families searching for answers that may never come.^[8]

Risk Factors

Understanding who faces elevated risk for developing Stevens-Johnson syndrome helps both patients and doctors remain vigilant. Genetics plays a fundamental role, with specific genes making certain individuals more susceptible to this severe reaction. Scientists have identified particular human leukocyte antigen types that increase vulnerability. For example, people carrying the HLA-B*1502 marker who take carbamazepine face dramatically higher risks of developing SJS. This genetic factor is more common in people of Han Chinese, Thai, and South Asian Indian ancestry.^[9]

Anyone who has experienced Stevens-Johnson syndrome in the past faces a high likelihood of developing it again if exposed to the same medication or chemically similar drugs. This makes maintaining detailed medical records and wearing medical alert identification critically important for survivors. Family history also matters—having a close blood relative who developed SJS increases your personal risk, suggesting that susceptibility runs in families through shared genetic factors.^[3]

People with compromised immune systems face elevated risks. This includes individuals living with HIV or AIDS, those undergoing chemotherapy for cancer, and people taking immunosuppressive medications after organ transplants. Their altered immune function makes them more vulnerable to developing severe medication reactions.^[2]

The timing of medication use also influences risk. Stevens-Johnson syndrome typically develops within the first few days to two months of starting a new medication, with most cases appearing within the first eight weeks. For antibiotics, reactions often occur within the first week, while anticonvulsant-related cases may take longer to develop. Medications with longer half-lives—meaning they remain in the body for extended periods—appear to cause SJS more frequently than chemically similar drugs that clear quickly from the system.^[8]

Adults generally develop Stevens-Johnson syndrome from medications, while children more commonly develop it from infections. However, these are tendencies rather than absolute rules, and either trigger can affect any age group. Elderly patients face not only increased risk of developing the condition but also worse outcomes if they do develop it, with higher mortality rates compared to younger patients.^[9]

Symptoms

Stevens-Johnson syndrome rarely strikes without warning. In most cases, the body sends out distress signals days before the characteristic rash appears. These early symptoms feel remarkably similar to influenza or a common cold, which is why the condition often goes unrecognized initially. People typically develop fever, often quite high, accompanied by a sore throat that makes swallowing uncomfortable. A persistent cough may develop, along with headaches and a general feeling of being unwell. Joint pain and fatigue are also common early complaints.^[3]

Within one to three days of these flu-like symptoms appearing, the distinctive rash emerges. This is when Stevens-Johnson syndrome reveals its true nature. The rash often begins on the face and upper chest before rapidly spreading to the arms, legs, and other parts of the body. What makes this rash different from ordinary drug reactions is its appearance and severity. The affected areas develop a peculiar target-like pattern, with darker centers surrounded by lighter rings. These aren’t typical itchy hives—instead, the skin becomes exquisitely painful to touch.^[1]

As the condition progresses, the rash transforms from flat spots into raised areas and then into blisters filled with fluid. These blisters are fragile and rupture easily, leaving behind raw, weeping sores. The skin begins to peel off in sheets, as if the person had suffered severe burns. When doctors lightly rub seemingly normal skin near the affected areas, the top layer slides off—a finding called the Nikolsky sign that helps confirm the diagnosis.^[4]

The mucous membranes suffer terribly in Stevens-Johnson syndrome. Inside the mouth, painful ulcers develop on the lips, tongue, and throughout the oral cavity. These sores make eating and drinking nearly impossible, and many patients drool because closing their mouth causes unbearable pain. The eyes become severely affected, with the conjunctiva (the clear covering of the eyeball) turning red and developing blisters. Discharge forms, and the eyelids may swell shut or stick together.^[2]

The genital and anal areas also develop blisters and erosions, making urination and bowel movements excruciating. For some patients, these wounds become so severe that normal elimination becomes a source of trauma. The throat may develop similar lesions, turning the simple act of swallowing saliva into an ordeal.^[3]

Throughout all of this, patients remain feverish and feel increasingly ill. The extensive skin damage leads to massive fluid loss from the body, similar to what happens with severe burns. This can quickly lead to dehydration and electrolyte imbalances—dangerous changes in blood chemistry that affect heart rhythm and other vital functions. Without treatment, blood pressure can drop dangerously low as the body goes into shock.^[5]

Prevention

Preventing Stevens-Johnson syndrome centers on identifying people at high risk before they receive potentially dangerous medications. In certain Asian countries, genetic testing for the HLA-B*1502 marker has become standard practice before prescribing carbamazepine. If the test comes back positive, doctors choose alternative medications that don’t carry the same risk. This approach has significantly reduced the number of carbamazepine-related SJS cases in these populations.^[9]

For anyone who has survived Stevens-Johnson syndrome, the most crucial preventive measure involves never taking the medication that caused the reaction again. This seems obvious, but complications arise because patients may not remember the exact name of the drug, especially years later. Survivors should maintain detailed records of the culprit medication, including its generic and brand names, and share this information with every healthcare provider they see. Wearing a medical alert bracelet or necklace that lists the dangerous medication provides protection even in emergencies when the person cannot communicate.^[3]

Chemical cousins of the original trigger medication must also be avoided. For instance, if someone developed SJS from one sulfa antibiotic, they should avoid all sulfonamide drugs. If an anti-epileptic caused the reaction, other medications in the same chemical class may also be dangerous. Pharmacists and doctors can help identify these related medications to ensure they never appear in future prescriptions.^[10]

When high-risk medications must be used, careful monitoring during the first several weeks of treatment allows early detection of problems. Patients should understand what warning signs to watch for and have clear instructions to stop the medication and seek immediate medical attention if any suspicious symptoms appear. Starting with the lowest effective dose and increasing gradually may reduce risk in some situations.^[16]

No supplements, vitamins, or lifestyle changes can prevent Stevens-Johnson syndrome once exposure to a trigger medication occurs. The reaction stems from individual genetic susceptibility combined with specific drug exposure, not from nutritional deficiencies or lifestyle factors. However, maintaining good overall health may help the body recover more effectively if SJS does develop.^[2]

For infectious causes in children, general infection prevention measures apply. These include good hand hygiene, staying up to date with vaccinations, and seeking prompt medical care for respiratory infections. However, because SJS from infections is unpredictable and rare, no specific preventive measures can eliminate the risk entirely.^[5]

Pathophysiology

Understanding what goes wrong inside the body during Stevens-Johnson syndrome helps explain why the condition is so severe and difficult to treat. At its core, SJS represents a catastrophic malfunction of the immune system. Instead of protecting the body, the immune system launches a devastating attack against the body’s own tissues, particularly the cells that form the skin and mucous membranes called keratinocytes.^[4]

The process begins when the triggering medication or its breakdown products in the body interact with immune cells in ways that scientists still don’t fully understand. These altered substances become targets for a specific type of immune cell called CD8+ cytotoxic T lymphocytes. These are the body’s assassin cells, normally deployed to kill virus-infected cells or cancer cells. In Stevens-Johnson syndrome, they mistakenly identify keratinocytes as enemies that must be destroyed.^[6]

The killing happens through multiple pathways. One major mechanism involves a protein called granulysin, which these immune cells release. Granulysin punches holes in the keratinocyte cell membranes, triggering a process called apoptosis—essentially programmed cell death. The concentration of granulysin found in the blister fluid of SJS patients correlates with how severe the disease becomes, suggesting it plays a central role in the destruction.^[8]

Another destructive pathway involves the Fas-FasL system. Activated immune cells express Fas ligand on their surfaces, which binds to Fas receptors on keratinocytes. This binding triggers a cascade of events inside the keratinocyte that leads to its death. Additionally, immune cells release other toxic proteins like perforin and granzyme B through a process called granule-mediated exocytosis. These proteins create channels in target cells and activate destructive enzymes that cause the cells to die from within.^[8]

Various signaling molecules called cytokines amplify and perpetuate the destruction. Tumor necrosis factor-alpha and interferon-gamma promote inflammation and may contribute to cell death through additional mechanisms. The interplay between these various pathways creates a self-reinforcing cycle of destruction that continues even after the triggering medication is stopped.^[15]

As keratinocytes throughout the skin and mucous membranes die, the connections between skin layers break down. The outermost layer, called the epidermis, separates from the layer beneath it (the dermis), forming fluid-filled blisters. When these blisters rupture, they leave behind raw, exposed tissue that has lost its protective barrier. This exposed tissue loses tremendous amounts of fluid and becomes vulnerable to bacterial invasion and infection.^[9]

The loss of skin barrier function has cascading effects throughout the body. Massive fluid shifts occur as plasma leaks from blood vessels into tissues and evaporates from exposed skin surfaces. This leads to dehydration, low blood pressure, and imbalances in crucial minerals like sodium, potassium, and calcium. The body struggles to maintain normal temperature as the temperature-regulating function of skin is lost. Heat escapes rapidly, yet the inflammatory processes create fever, placing conflicting demands on an already stressed system.^[14]

The exposed wounds become breeding grounds for bacteria. Even though patients receive antibiotics, infections frequently develop and can spread into the bloodstream, causing sepsis—a life-threatening condition where infection triggers widespread inflammation throughout the body. The combination of fluid loss, infection risk, and metabolic chaos explains why Stevens-Johnson syndrome requires intensive care management similar to severe burn injuries.^[10]

The eyes suffer particularly devastating damage through similar mechanisms. The conjunctiva and cornea lose their protective epithelial layer, becoming inflamed and prone to scarring. This acute damage can lead to permanent complications including dry eyes, chronic pain, sensitivity to light, scarring between the eyelid and eyeball, and vision loss or blindness.^[4]